Respiratory Sounds: Clinical Trials

11 trials for Respiratory Sounds, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 11 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 6, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 26Completed 3, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Respiratory Sounds: new trials by email Literature Review of Respiratory Sounds trials Research Report on Respiratory Sounds

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genes, Soy Isoflavones, and Virus
Soy Isoflavone Nutritional Supplements - Wheezing
Phase 1 / Phase 2Not yet recruitingAnn & Robert H Lurie Children's Hospital of Chicago602026-10-012026-09-18
Pharmacological Intervention for Symptomatic Snoring
SAS2094AH and SAS2094BH, SAS2094AL and SAS2094BL, Placebo - Snoring
Phase 1 / Phase 2CompletedBrigham and Women's Hospital272018-12-172019-12-12
A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma
VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation System, 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer - Wheezing, Reactive Airway Disease
Phase 1CompletedVectura Limited172017-12-182019-10-21
Effect of Nasal Steroids in Snoring Intensity
nasal spray Budesonide, Nasal spray Normal Saline - Snoring
Phase 1CompletedIoannis Koutsourelakis242013-04-012013-09-16
Study to Determine Results of Vibratory Stimulus on Subject's Neck
Kai Strap - Sleep Apnea, Snoring
Phase 1CompletedKai Medical, Inc.1002011-11-012012-03-20
Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Epinephrine Inhalation Aerosol, HFA, Epinephrine Inhalation Aerosol - Asthma, Bronchospasm
Phase 1 / Phase 2CompletedAmphastar Pharmaceuticals, Inc.232010-08-012017-07-25
Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
E004 (epinephrine inhalation aerosol), 90 mcg/actuation, E004 Placebo, E004 (epinephrine inhalation aerosol), 125 mcg - Asthma
Phase 1 / Phase 2TerminatedAmphastar Pharmaceuticals, Inc.92009-12-012018-05-16
Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood
Cholecalciferol D3, Placebo tablet - Asthma
Phase 1Active not recruitingCopenhagen Studies on Asthma in Childhood6002009-03-012026-03-19
Allergy Immunotherapy for the Reduction of Asthma
Allergen extracts (subcutaneous injections), Standard of care - Wheezing, Asthma
Phase 1 / Phase 2CompletedAlbert Einstein College of Medicine582008-10-012019-05-28
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
Polidocanol Sclerotherapy - Apnea, Snoring
Phase 1 / Phase 2UnknownLiaoyang Central Hospital302006-12-012006-11-22
Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.
KEEPASLEEP enhanced breathing device - Snoring, Sleep Apnea Syndromes
Phase 1UnknownMiller, Chipp St. Kevin, M.D.302004-06-012005-09-21

Narrower conditions

Snoring (5)  ·  Asthma (4)  ·  Apnea (2)  ·  Dyspnea (2)  ·  Hypersensitivity (2)  ·  Sleep Apnea Syndromes (2)  ·  Bronchial Spasm (1)  ·  Eczema (1)  ·  Infections (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Sleep Apnea, Obstructive (1)  ·  Status Asthmaticus (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (11)  ·  Signs and Symptoms (11)  ·  Signs and Symptoms, Respiratory (11)  ·  Respiratory Tract Diseases (8)  ·  Lung Diseases (5)  ·  Lung Diseases, Obstructive (5)  ·  Respiration Disorders (5)  ·  Bronchial Diseases (4)  ·  Hypersensitivity, Immediate (4)  ·  Immune System Diseases (4)  ·  Respiratory Hypersensitivity (4)  ·  Dyssomnias (3)  ·  Nervous System Diseases (3)  ·  Sleep Disorders, Intrinsic (3)

Interventions

Budesonide (2)  ·  Epinephrine (2)  ·  Inhalation (1)  ·  Injections, Subcutaneous (1)  ·  Saline Solution (1)  ·  Standard of Care (1)

Sponsors

Amphastar Pharmaceuticals, Inc. (2)  ·  Albert Einstein College of Medicine (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Brigham and Women's Hospital (1)  ·  Copenhagen Studies on Asthma in Childhood (1)  ·  Ioannis Koutsourelakis (1)  ·  Kai Medical, Inc. (1)  ·  Liaoyang Central Hospital (1)  ·  Miller, Chipp St. Kevin, M.D. (1)  ·  Vectura Limited (1)

Countries

United States (8)  ·  Denmark (1)  ·  Greece (1)

Top investigators

Chipp K. Miller, M.D. (1)  ·  Gabriele de Vos, M.D., M.Sc. (1)  ·  Gary Burgess, MD (1)  ·  Ioannis Koutsourelakis, MD (1)  ·  Jim Shi, M.D., Ph.D. (1)  ·  Rajesh Kumar, MD, MSCI (1)  ·  Scott A Sands, PhD (1)

Results publications

PMID 23176889, PMID 23706713, PMID 26813208, PMID 29077711, PMID 31381020, PMID 32091548, PMID 32150492, PMID 32423275, PMID 33289844, PMID 33418053, PMID 33653805, PMID 35105560, PMID 36184023, PMID 38072183, PMID 39077939, PMID 40471069, PMID 40865727, PMID 42149595

NIH funding

2008 (1)